D’Avanzo F, Rigon L, Zanetti A, Tomanin R. Mucopolysaccharidosis type II: one hundred years of research, diagnosis, and treatment. Int J Mol Sci. 2020;21:E1258.

Article  Google Scholar 

Wraith JE, Scarpa M, Beck M, Bodamer OA, De Meirleir L, Guffon N, et al. Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy. Eur J Pediatr. 2008;167:267–77.

Article  CAS  PubMed  Google Scholar 

Wraith JE, Beck M, Giugliani R, Clarke J, Martin R, Muenzer J, et al. Initial report from the Hunter Outcome Survey. Genet Med Off J Am Coll Med Genet. 2008;10:508–16.

Google Scholar 

Parini R, Jones SA, Harmatz PR, Giugliani R, Mendelsohn NJ. The natural history of growth in patients with Hunter syndrome: data from the Hunter Outcome Survey (HOS). Mol Genet Metab. 2016;117:438–46.

Article  CAS  PubMed  Google Scholar 

Wiśniewska K, Wolski J, Gaffke L, Cyske Z, Pierzynowska K, Węgrzyn G. Misdiagnosis in mucopolysaccharidoses. J Appl Genet. 2022;63:475–95.

Article  PubMed  Google Scholar 

Vellodi A, Young E, Cooper A, Lidchi V, Winchester B, Wraith JE. Long-term follow-up following bone marrow transplantation for Hunter disease. J Inherit Metab Dis. 1999;22:638–48.

Article  CAS  PubMed  Google Scholar 

Guffon N, Bertrand Y, Forest I, Fouilhoux A, Froissart R. Bone marrow transplantation in children with Hunter syndrome: outcome after 7 to 17 years. J Pediatr. 2009;154:733–7.

Article  PubMed  Google Scholar 

Scarpa M. Mucopolysaccharidosis type II. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJ, et al., editors. GeneReviews® [Internet]. Seattle: University of Washington, Seattle; 1993 [cited 2024 Jul 2]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK1274/.

Barth AL, de Magalhães TSPC, Reis ABR, de Oliveira ML, Scalco FB, Cavalcanti NC, et al. Early hematopoietic stem cell transplantation in a patient with severe mucopolysaccharidosis II: a 7 years follow-up. Mol Genet Metab Rep. 2017;12:62–8.

PubMed  PubMed Central  Google Scholar 

Sreekantam S, Smith L, Stewart C, Kearney S, Lawson S, Raiman J, et al. Efficacy of early haematopoietic stem cell transplantation versus enzyme replacement therapy on neurological progression in severe Hunter syndrome: case report of siblings and literature review. Mol Genet Metab Rep. 2022;32: 100881.

CAS  PubMed  PubMed Central  Google Scholar 

Parini R, Deodato F. Intravenous enzyme replacement therapy in mucopolysaccharidoses: clinical effectiveness and limitations. Int J Mol Sci. 2020;21:2975.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tuschl K, Gal A, Paschke E, Kircher S, Bodamer OA. Mucopolysaccharidosis type II in females: case report and review of literature. Pediatr Neurol. 2005;32:270–2.

Article  PubMed  Google Scholar 

Manara R, Rampazzo A, Cananzi M, Salviati L, Mardari R, Drigo P, et al. Hunter syndrome in an 11-year old girl on enzyme replacement therapy with idursulfase: brain magnetic resonance imaging features and evolution. J Inherit Metab Dis. 2010;33(Suppl 3):S67-72.

Article  PubMed  Google Scholar 

Jurecka A, Krumina Z, Żuber Z, Różdżyńska-Świątkowska A, Kłoska A, Czartoryska B, et al. Mucopolysaccharidosis type II in females and response to enzyme replacement therapy. Am J Med Genet A. 2012;158A:450–4.

Article  PubMed  Google Scholar 

Ago Y, Rintz E, Musini KS, Ma Z, Tomatsu S. Molecular mechanisms in pathophysiology of mucopolysaccharidosis and prospects for innovative therapy. Int J Mol Sci. 2024;25:1113.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kowalewski B, Lamanna WC, Lawrence R, Damme M, Stroobants S, Padva M, et al. Arylsulfatase G inactivation causes loss of heparan sulfate 3-O-sulfatase activity and mucopolysaccharidosis in mice. Proc Natl Acad Sci. 2012;109:10310–5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Velde HM, Reurink J, Held S, Li CHZ, Yzer S, Oostrik J, et al. Usher syndrome type IV: clinically and molecularly confirmed by novel ARSG variants. Hum Genet. 2022;141:1723–38.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rasheeedah I, Patrick O, Abdullateef A, Mohammed A, Sherifat K, Gbadebo I. Challenges in the management of mucopolysaccharidosis type II (Hunter’s syndrome) in a developing country: a case report. Ethiop J Health Sci. 2015;25:279–82.

Article  PubMed  PubMed Central  Google Scholar 

Chan M-J, Liao H-C, Gelb MH, Chuang C-K, Liu M-Y, Chen H-J, et al. Taiwan National Newborn Screening Program by tandem mass spectrometry for mucopolysaccharidoses types I, II, and VI. J Pediatr. 2019;205:176–82.

Article  CAS  PubMed  Google Scholar 

Chien Y-H, Lee N-C, Chen P-W, Yeh H-Y, Gelb MH, Chiu P-C, et al. Newborn screening for Morquio disease and other lysosomal storage diseases: results from the 8-plex assay for 70,000 newborns. Orphanet J Rare Dis. 2020;15:38.

Article  PubMed  PubMed Central  Google Scholar 

Chuang C-K, Tu Y-R, Lee C-L, Lo Y-T, Chang Y-H, Liu M-Y, et al. Updated confirmatory diagnosis for mucopolysaccharidoses in Taiwanese infants and the application of gene variants. Int J Mol Sci. 2022;23:9979.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lin H-Y, Chang Y-H, Lee C-L, Tu Y-R, Lo Y-T, Hung P-W, et al. Newborn screening program for mucopolysaccharidosis type II and long-term follow-up of the screen-positive subjects in Taiwan. J Pers Med. 2022;12:1023.

Article  PubMed  PubMed Central  Google Scholar 

Muenzer J. The mucopolysaccharidoses: a heterogeneous group of disorders with variable pediatric presentations. J Pediatr. 2004;144:S27-34.

Article  CAS  PubMed  Google Scholar 

Filocamo M, Tomanin R, Bertola F, Morrone A. Biochemical and molecular analysis in mucopolysaccharidoses: what a paediatrician must know. Ital J Pediatr. 2018;44:129.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zanetti A, D’Avanzo F, Bertoldi L, Zampieri G, Feltrin E, De Pascale F, et al. Setup and validation of a targeted next-generation sequencing approach for the diagnosis of lysosomal storage disorders. J Mol Diagn JMD. 2020;22:488–502.

Article  CAS  PubMed  Google Scholar 

Ghaffari SR, Rafati M, Shadnoush M, Pourbabaee S, Aghighi M, Mirab Samiee S, et al. Molecular characterization of a large cohort of mucopolysaccharidosis patients: Iran mucopolysaccharidosis RE-diagnosis study (IMPRESsion). Hum Mutat. 2022;43:e1-23.

Article  CAS  PubMed  Google Scholar 

Gul R, Firasat S, Schubert M, Ullah A, Peña E, Thuesen ACB, et al. Identifying the genetic causes of phenotypically diagnosed Pakistani mucopolysaccharidoses patients by whole genome sequencing. Front Genet. 2023;14:1128850.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lau H, Harmatz P, Botha J, Audi J, Link B. Clinical characteristics and somatic burden of patients with mucopolysaccharidosis II with or without neurological involvement: an analysis from the Hunter Outcome Survey. Mol Genet Metab Rep. 2023;37: 101005.

PubMed  PubMed Central  Google Scholar 

Żuber Z, Kieć-Wilk B, Kałużny Ł, Wierzba J, Tylki-Szymańska A. Diagnosis and management of mucopolysaccharidosis type II (Hunter syndrome) in Poland. Biomedicines. 2023;11:1668.

Article  PubMed  PubMed Central  Google Scholar 

Young ID, Harper PS. Mild form of Hunter’s syndrome: clinical delineation based on 31 cases. Arch Dis Child. 1982;57:828–36.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jones SA, Almássy Z, Beck M, Burt K, Clarke JT, Giugliani R, et al. Mortality and cause of death in mucopolysaccharidosis type II-a historical review based on data from the Hunter Outcome Survey (HOS). J Inherit Metab Dis. 2009;32:534–43.

Article  CAS  PubMed